| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals
|
Salvarese, N.
|
|
2019
|
118-119 |
S1 |
p. S28
|
artikel
|
| 2 |
A clinical introduction of somatostatin receptor (SSTR) imaging with 68Ga-DOTATOC PET/TC
|
Agostini, S.
|
|
2019
|
118-119 |
S1 |
p. S46
|
artikel
|
| 3 |
A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors
|
Ilias, Ioannis
|
|
2008
|
118-119 |
S1 |
p. S27-S34
8 p.
|
artikel
|
| 4 |
A comparison of chelate labeling with Ac-225: application to PSMA-targeting radiopharmaceuticals
|
Kelly, J.
|
|
2019
|
118-119 |
S1 |
p. S11
|
artikel
|
| 5 |
Ac-225 vs Lu-177 radioimmunoconjugates in vitro and in vivo
|
Lakes, A.
|
|
2019
|
118-119 |
S1 |
p. S15
|
artikel
|
| 6 |
A 68Ga-labelled PET probe for selective imaging of αvβ8-integrin
|
Notni, J.
|
|
2019
|
118-119 |
S1 |
p. S18-S19
|
artikel
|
| 7 |
An alternative separation strategy for the isolation of Ac and Ra isotopes from thorium targets irradiated with high energy protons
|
Baimukhanova, A.
|
|
2019
|
118-119 |
S1 |
p. S32
|
artikel
|
| 8 |
A new approach for labelling near-infrared dyes with 99mTc for combined SPECT and photoacoustic imaging of calcium accretion
|
Slikboer, S.
|
|
2019
|
118-119 |
S1 |
p. S2
|
artikel
|
| 9 |
A new family of tacn derivatives for 64Cu and 68Ga chelation
|
Denat, F.
|
|
2019
|
118-119 |
S1 |
p. S11-S12
|
artikel
|
| 10 |
A platform for delivery of small molecules using trans-cyclooctene-functionalized pluronic F127 micelles
|
Ahmad, Z.
|
|
2019
|
118-119 |
S1 |
p. S64
|
artikel
|
| 11 |
A proof of concept study with FSC-based hybrid imaging agents for pretargeting applications
|
Summer, D.
|
|
2019
|
118-119 |
S1 |
p. S33-S34
|
artikel
|
| 12 |
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons
|
Boschi, A.
|
|
2019
|
118-119 |
S1 |
p. S47
|
artikel
|
| 13 |
A series of radiolabeled mannosylated dextran derivatives for sentinel lymph node detection
|
Papasavva, A.
|
|
2019
|
118-119 |
S1 |
p. S29
|
artikel
|
| 14 |
Assessment of 99mTc/186Re-tricarbonyl-NODAGA and NOTA complexes in the design of radiolabeled somatostatin receptor-targeting agents
|
Makris, G.
|
|
2019
|
118-119 |
S1 |
p. S24
|
artikel
|
| 15 |
Automated production of Cu-64, Zr-89, Ga-68, Ti-45, I-123 and I-124 with a medical cyclotron, using a commercial solid target system
|
Malinconico, M.
|
|
2019
|
118-119 |
S1 |
p. S6
|
artikel
|
| 16 |
A versatile immune-stimulatory radiometal complex for combination radiotherapy and immunotherapy
|
Rathmann, S.
|
|
2019
|
118-119 |
S1 |
p. S12-S13
|
artikel
|
| 17 |
Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapy and magnetic hyperthermia
|
Gaweda, W.
|
|
2019
|
118-119 |
S1 |
p. S37
|
artikel
|
| 18 |
Bifunctional cyclam derivatives with a bis(phosphinate) pendant arm as efficient chelators for copper radionuclides
|
Pietzsch, H.J.
|
|
2019
|
118-119 |
S1 |
p. S40
|
artikel
|
| 19 |
Bifunctional dendrimer scaffold leads to increased tumor uptake
|
Cook, B.
|
|
2019
|
118-119 |
S1 |
p. S16
|
artikel
|
| 20 |
Bimodal prostate specific membrane antigen ligands for intra-operative tumor detection and photodynamic therapy of prostate cancer
|
Derks, Y.
|
|
2019
|
118-119 |
S1 |
p. S14
|
artikel
|
| 21 |
Bioconjugated gold nanoparticles for cancer theranostics
|
Silva, F.
|
|
2019
|
118-119 |
S1 |
p. S52
|
artikel
|
| 22 |
Bioconjugates of gold nanoparticles with trastuzumab labelled with 211At for alpha nanobrachyterapy
|
Dziawer, L.
|
|
2019
|
118-119 |
S1 |
p. S64
|
artikel
|
| 23 |
Bio-inspired peptoid chelators for imaging and targeted alpha therapy
|
Rees, J.
|
|
2019
|
118-119 |
S1 |
p. S45
|
artikel
|
| 24 |
Biological profile of 111In-SB9, a new GRPR-antagonist radioligand for prostate cancer imaging: the role of neprilysin on tumor targeting efficacy in mice
|
Maina, Th.
|
|
2019
|
118-119 |
S1 |
p. S53
|
artikel
|
| 25 |
Bisarene complexes of 99mTc and Re: Developing a new platform for imaging and (radio) therapy
|
Braband, H.
|
|
2019
|
118-119 |
S1 |
p. S1-S2
|
artikel
|
| 26 |
Bis(diphosphino)maleic anhydride as a bifunctional chelator for technetium-99m
|
Hungnes, I.
|
|
2019
|
118-119 |
S1 |
p. S25-S26
|
artikel
|
| 27 |
Calix[4]crown-6 scaffold for the complexation of barium and radium
|
Mamat, C.
|
|
2019
|
118-119 |
S1 |
p. S14
|
artikel
|
| 28 |
Click chemistry: an efficient strategy for the labeling of proteins
|
Lodhi, N.A.
|
|
2019
|
118-119 |
S1 |
p. S4
|
artikel
|
| 29 |
“Click to ligand/conjugate” for facile labeling with Al[18F]F, 68Ga, 111In or 64Cu
|
Walther, M.
|
|
2019
|
118-119 |
S1 |
p. S35
|
artikel
|
| 30 |
Combined radio- and immunotherapy treatments for triple-negative breast cancer
|
Vito, A.
|
|
2019
|
118-119 |
S1 |
p. S22
|
artikel
|
| 31 |
Comparative evaluation of anti-EGFR affibody molecules labelled with gallium-68 and zirconium-89 using DFO chelator
|
Maryam, O.
|
|
2019
|
118-119 |
S1 |
p. S66
|
artikel
|
| 32 |
Comparative radium-223 labeling with NOTA and DOTA-somatostatin derivatives for a potential use in targeted cancer therapy
|
Riondato, M.
|
|
2019
|
118-119 |
S1 |
p. S50-S51
|
artikel
|
| 33 |
Comparison of the IGG-100 vs the ITG 68Ge/68Ga generators: impact of impurities on radiolabeling
|
Amor-Coarasa, A.
|
|
2019
|
118-119 |
S1 |
p. S47-S48
|
artikel
|
| 34 |
Controlling technetium-99 oxidation states under legacy waste and environmental conditions
|
Francesconi, L.
|
|
2019
|
118-119 |
S1 |
p. S25
|
artikel
|
| 35 |
Copper-64 and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells
|
Croci, S.
|
|
2019
|
118-119 |
S1 |
p. S44
|
artikel
|
| 36 |
Cross-bridged cyclams with bis (phosphinic acid) pendants for a fast Cu(II) complexation: towards efficient 64Cu labeling
|
Kubicek, V.
|
|
2019
|
118-119 |
S1 |
p. S10-S11
|
artikel
|
| 37 |
64Cu radiolabeling of polymeric micellar nanoparticles
|
Mattingly, S.
|
|
2019
|
118-119 |
S1 |
p. S61
|
artikel
|
| 38 |
Current experience with mIBG therapy in combination with chemotherapy and radiosensitizers
|
Gaze, Mark N.
|
|
2008
|
118-119 |
S1 |
p. S21-S26
6 p.
|
artikel
|
| 39 |
Cyclopentadienyl tricarbonyl 99mTc/Re complexes containing spirocyclic piperidine moiety as nonselective sigma receptor ligands for tumor imaging and therapy
|
Wang, X.
|
|
2019
|
118-119 |
S1 |
p. S6
|
artikel
|
| 40 |
Cyclotron-based production of Tc-99m and other metals
|
Schaffer, P.
|
|
2019
|
118-119 |
S1 |
p. S6-S7
|
artikel
|
| 41 |
Desmin- and vimentin-targeting tracer 99mTc-GlcNAc-PEI for idiopathic pulmonary fibrosis imaging with SPECT/CT in a mice model
|
Zhang, D.
|
|
2019
|
118-119 |
S1 |
p. S29
|
artikel
|
| 42 |
Deuterium isotopic substitution in 64CuATSM: effects on redox potential and hypoxic trapping
|
Blower, J.
|
|
2019
|
118-119 |
S1 |
p. S42
|
artikel
|
| 43 |
Developing radioimmunotherapy of osteosarcoma using comparative oncology approach
|
Dadachova, E.
|
|
2019
|
118-119 |
S1 |
p. S21
|
artikel
|
| 44 |
Development and characterization of a 177Lu-labeled anti-prostate stem cell antigen (PSCA) monoclonal antibody for metastatic prostate cancer
|
Striese, F.
|
|
2019
|
118-119 |
S1 |
p. S20
|
artikel
|
| 45 |
Development and evaluation of a 99mTc(III) ‘4 + 1’ complex derived from estradiol for imaging breast cancer
|
Tejeria, M.E.
|
|
2019
|
118-119 |
S1 |
p. S4
|
artikel
|
| 46 |
Development of a MUC1-targeting PET probe for ovarian cancer
|
Fung, K.
|
|
2019
|
118-119 |
S1 |
p. S57-S58
|
artikel
|
| 47 |
Development of FR-targeting agent for SPECT imaging of atherosclerosis
|
Xuejun, W.
|
|
2019
|
118-119 |
S1 |
p. S66-S67
|
artikel
|
| 48 |
Development of 68Ga-labelled tetrazines for pretargeted tumour imaging with PET
|
Edem, P.
|
|
2019
|
118-119 |
S1 |
p. S57
|
artikel
|
| 49 |
Development of 99mTc-labeled tetrazines with favorable brain pharmacokinetics for bioorthogonal SPECT imaging
|
Zhang, X.
|
|
2019
|
118-119 |
S1 |
p. S3
|
artikel
|
| 50 |
Development of scandium-exopolysaccharide complexes as a theranostic tool in bone oncology
|
Mazza, M.
|
|
2019
|
118-119 |
S1 |
p. S22-S23
|
artikel
|
| 51 |
Diagnosis and therapy of carcinoid tumors—current state of the art and future directions
|
Khan, Mazhar U.
|
|
2008
|
118-119 |
S1 |
p. S77-S91
15 p.
|
artikel
|
| 52 |
Direct isolation of 89Zr-chloride using a solid-phase tributyl phosphate resin
|
Graves, S.
|
|
2019
|
118-119 |
S1 |
p. S14-S15
|
artikel
|
| 53 |
Drug formulation and its impact on the distribution of [99mTc] Tc-tetrazines for pretargeting applications via inverse-electron demand Diels-Alder chemistry
|
Bilton, H.
|
|
2019
|
118-119 |
S1 |
p. S26
|
artikel
|
| 54 |
Dual modal fluorescence/SPECT imaging probes: 4-Amino-1,8-naphthalimide 99mTc/Re-tricarbonyl complexes
|
Murrell, E.
|
|
2019
|
118-119 |
S1 |
p. S2
|
artikel
|
| 55 |
Dual-modality liver function imaging agent: neolactosylated albumin stabilized gold nanoclusters
|
Xue, J.
|
|
2019
|
118-119 |
S1 |
p. S41-S42
|
artikel
|
| 56 |
Effect of the radiometal on the pharmacokinetics of a PSMA-targeting ligand for radioligand therapy
|
Kelly, J.
|
|
2019
|
118-119 |
S1 |
p. S54
|
artikel
|
| 57 |
Efficacy of 44Sc production from natural calcium
|
Wojdowska, W.
|
|
2019
|
118-119 |
S1 |
p. S32
|
artikel
|
| 58 |
Enhancing PET signal at target tissue in vivo: dendritic hydroxypyridinone peptide conjugates for molecular imaging with gallium-68
|
Ma, M.
|
|
2019
|
118-119 |
S1 |
p. S12
|
artikel
|
| 59 |
Evaluating HOPO chelators with therapeutic radioisotopes for theranostic applications in immunoPET imaging and radioimmunotherapy
|
Tully, K.
|
|
2019
|
118-119 |
S1 |
p. S49
|
artikel
|
| 60 |
Evaluation of a somastostatin receptor based theranostic agent with an albumin binding via structural modifications using a truncated Evans Blue molecule
|
Bandara, N.
|
|
2019
|
118-119 |
S1 |
p. S21
|
artikel
|
| 61 |
Evaluation of Ga-68-DOTA-GGNle-CycMSHhex for melanoma imaging
|
Yang, J.
|
|
2019
|
118-119 |
S1 |
p. S34-S35
|
artikel
|
| 62 |
Evaluation of [99mTc]Tc(CO)3 + moiety labeled alpha-melanocyte stimulating hormone derived peptide conjugates for potential melanoma imaging
|
Weissflog, S.
|
|
2019
|
118-119 |
S1 |
p. S55
|
artikel
|
| 63 |
Evaluation of [227Th]thorium chelation of hydroxypyridinone- and picolinic acid-containing ligands to simulate 226Th chelation
|
Li, Y.
|
|
2019
|
118-119 |
S1 |
p. S38
|
artikel
|
| 64 |
Fully automated zirconium-89 antibody labeling and purification
|
Vugts, D.
|
|
2019
|
118-119 |
S1 |
p. S23
|
artikel
|
| 65 |
68Ga- and 177Lu-radiolabelling chemistry of DO3A-VS-Cys40-Exendin-4 and differences of the tracer pancreatic uptake in various species
|
Velikyan, I.
|
|
2019
|
118-119 |
S1 |
p. S55
|
artikel
|
| 66 |
68Ga-curcumin-based bifunctional ligands for Alzheimer’s disease diagnosis
|
Orteca, G.
|
|
2019
|
118-119 |
S1 |
p. S43-S44
|
artikel
|
| 67 |
68Ga labelled bacterial siderophore for infection imaging: a proof of principle
|
Zhai, C.
|
|
2019
|
118-119 |
S1 |
p. S62
|
artikel
|
| 68 |
68Ga-labelled, fluorescent siderophores: dual imaging potential in Aspergillus fumigatus infections
|
Kochinke, L.
|
|
2019
|
118-119 |
S1 |
p. S62-S63
|
artikel
|
| 69 |
68Ga labelling of a 12-mer peptide selective for tissue transglutaminase 2
|
Ackermann, U.
|
|
2019
|
118-119 |
S1 |
p. S41
|
artikel
|
| 70 |
Heterobivalent bioconjugates based on the FSC-scaffold targeting folate receptor and alphavbeta3 integrin
|
Kaeopookum, P.
|
|
2019
|
118-119 |
S1 |
p. S37-S38
|
artikel
|
| 71 |
Host-guest based pretargeting with 89Zr- and 177Lu-labeled adamantane based radioligands
|
Jallinoja, V.
|
|
2019
|
118-119 |
S1 |
p. S65
|
artikel
|
| 72 |
Imaging folate-receptor expression using 55Co-labeled albumin-binding folic acid derivatives
|
Fernandez, S.
|
|
2019
|
118-119 |
S1 |
p. S58
|
artikel
|
| 73 |
Imaging the third gasotransmitter hydrogen sulfide using a 99mTc-labeled polyhydroxy weak acid
|
Jeong, J.
|
|
2019
|
118-119 |
S1 |
p. S53-S54
|
artikel
|
| 74 |
Immuno-PET imaging of human tumor necrosis factor alpha in a transgenic mouse model of rheumatoid arthritis
|
Beckford, V.
|
|
2019
|
118-119 |
S1 |
p. S16-S17
|
artikel
|
| 75 |
Improving excretory pathways of technetium-99m SPECT imaging agents based on bioorthogonal Diels-Alder click chemistry
|
Walsh, J.
|
|
2019
|
118-119 |
S1 |
p. S65
|
artikel
|
| 76 |
Indium(III) complex with a bifunctional agent for dual targeting of cancer cells
|
Vultos, F.
|
|
2019
|
118-119 |
S1 |
p. S44
|
artikel
|
| 77 |
Influence of treatment with antimicrobial agents in the diagnosis of microbiological infections with technetium-99m labelled caspofungin
|
Bentura, M.
|
|
2019
|
118-119 |
S1 |
p. S55-S56
|
artikel
|
| 78 |
Investigation of the effect of trace metals on radiolabelling tris(3-hydroxy-4-pyridinone) with 68Ga
|
Cusnir, R.
|
|
2019
|
118-119 |
S1 |
p. S41
|
artikel
|
| 79 |
In vitro and in vivo evaluation of novel 89Zr chelators
|
Denat, F.
|
|
2019
|
118-119 |
S1 |
p. S44-S45
|
artikel
|
| 80 |
In vitro preliminary study of 64Cu-labeled anti-CD20 mAb for pretargeted immuno-PET
|
Kim, H.
|
|
2019
|
118-119 |
S1 |
p. S64
|
artikel
|
| 81 |
In vitro studies of Bi2S3 nanoparticles as radiosensitizer in MCF7 cells
|
Galain, I.
|
|
2019
|
118-119 |
S1 |
p. S51-S52
|
artikel
|
| 82 |
In vivo assessment of 99mTc-labeled CCR2-binding peptide in a mouse model of myocardial infarction
|
Lee, W.
|
|
2019
|
118-119 |
S1 |
p. S18
|
artikel
|
| 83 |
Isolation of 99mTc from the gamma/proton irradiated 100Mo target
|
Gumiela, M.
|
|
2019
|
118-119 |
S1 |
p. S30
|
artikel
|
| 84 |
Labeling of a drug delivery system based on carbon nanotubes with 68Ga and 64Cu: an in vivo biodistribution study
|
Gammon, S.
|
|
2019
|
118-119 |
S1 |
p. S38-S39
|
artikel
|
| 85 |
LARAMED: a LAboratoty of RAdioisotopes for MEDicine
|
Martini, P.
|
|
2019
|
118-119 |
S1 |
p. S30-S31
|
artikel
|
| 86 |
LC-MS and MALDI-TOF supported metabolism studies of the selective alphavbeta3 RGDechi peptide and of the corresponding [99mTc(N)PNP]-tagged derivatives
|
Bolzati, C.
|
|
2019
|
118-119 |
S1 |
p. S63-S64
|
artikel
|
| 87 |
Ligand development for the Radiometal Hg-197(m)
|
Gilpin, I.
|
|
2019
|
118-119 |
S1 |
p. S37
|
artikel
|
| 88 |
Linking computational, spectroscopic, and radiochemical methods to design the next-generation of radiometal chelators
|
Khozeimeh, A.
|
|
2019
|
118-119 |
S1 |
p. S34
|
artikel
|
| 89 |
177Lu-labelled peptidomimetics: novel minigastrin analogues for improved tumour targeting
|
Grob, N.
|
|
2019
|
118-119 |
S1 |
p. S20
|
artikel
|
| 90 |
Lu-177 radiolabeled ultrasmall C’ dot nanoparticle melanoma theranostics
|
Chen, F.
|
|
2019
|
118-119 |
S1 |
p. S60
|
artikel
|
| 91 |
Manganese carbonyl derivatives as CO source for preparation of [99mTc(CO)3(H2O)3]+
|
Yang, W.
|
|
2019
|
118-119 |
S1 |
p. S25
|
artikel
|
| 92 |
Medically interesting radiolanthanide terbium-161: from production towards clinical application
|
Gracheva, N.
|
|
2019
|
118-119 |
S1 |
p. S8-S9
|
artikel
|
| 93 |
Meta[131I]iodobenzylguanidine therapy for patients with metastatic and unresectable pheochromocytoma and paraganglioma
|
Goldsby, Robert E.
|
|
2008
|
118-119 |
S1 |
p. S49-S62
14 p.
|
artikel
|
| 94 |
Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors
|
Pryma, Daniel
|
|
2008
|
118-119 |
S1 |
p. S3-S8
6 p.
|
artikel
|
| 95 |
Metaiodobenzylguanidine in the diagnosis and therapy of neuroendocrine tumors
|
Coleman, R. Edward
|
|
2008
|
118-119 |
S1 |
p. S1-
1 p.
|
artikel
|
| 96 |
Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
|
De Zanger, R.
|
|
2019
|
118-119 |
S1 |
p. S50
|
artikel
|
| 97 |
Moving towards clinical translation of bioorthogonal chemistry: preparation and testing of a 99mTc instant kit for imaging and treating bone injury using inverse-electron demand Diels-Alder (IEDDA) chemistry
|
Mercanti, N.
|
|
2019
|
118-119 |
S1 |
p. S30
|
artikel
|
| 98 |
99mTc-DGA1, a new radiotracer derived from a non-peptidic CCK2R-antagonist, showing excellent prospects for diagnostic imaging of CCK2R-positive human tumors with SPECT
|
Maina, Th.
|
|
2019
|
118-119 |
S1 |
p. S52-S53
|
artikel
|
| 99 |
99mTc-labeled triphenyl phosphonium cations as potential metallic diagnostic agents for multidrug resistance
|
Li, X.
|
|
2019
|
118-119 |
S1 |
p. S58
|
artikel
|
| 100 |
99mTc-labeled zinc-dipicolylamine complex for cell death imaging
|
Ogawa, K.
|
|
2019
|
118-119 |
S1 |
p. S61
|
artikel
|
| 101 |
[99mTc]Tc-HYNIC-MGS5 and [68Ga]Ga-DOTA-MGS5: two novel imaging probes for cholecystokinin-2 receptor targeting
|
Klingler, M.
|
|
2019
|
118-119 |
S1 |
p. S16
|
artikel
|
| 102 |
99mTechnetium site-specific labeling of S-alkylated homodimeric N-acetyl cysteine ethyl ester(NACET) DTPA derivative for neuro imaging
|
Hazari, P.
|
|
2019
|
118-119 |
S1 |
p. S58-S59
|
artikel
|
| 103 |
Nanoprobes for nuclear imaging and/or therapy: how FFF techniques could characterize these nanometric scaffolds
|
Huclier-Markai, S.
|
|
2019
|
118-119 |
S1 |
p. S36-S37
|
artikel
|
| 104 |
Neuropeptide Y short analogue as potential breast cancer diagnostic and therapeutic agent
|
Tejeria, M.E.
|
|
2019
|
118-119 |
S1 |
p. S23
|
artikel
|
| 105 |
Neutral fac-[Re(I)/Tc(I)(CO)3(PO)L] complexes with substituted pyridine as a monodentate ligand
|
Vlastara, M.
|
|
2019
|
118-119 |
S1 |
p. S28
|
artikel
|
| 106 |
Neutral oxorhenium(V) complexes of an N3S donor set that bind to amyloid-beta plaques
|
Spyrou, B.
|
|
2019
|
118-119 |
S1 |
p. S30
|
artikel
|
| 107 |
New bifunctional chelators for diagnostic and therapeutic radioisotopes
|
Li, L.
|
|
2019
|
118-119 |
S1 |
p. S10
|
artikel
|
| 108 |
New library of ligands for radiometals
|
Boninsegni, A.
|
|
2019
|
118-119 |
S1 |
p. S38
|
artikel
|
| 109 |
New 52Mn complexes for cell labelling and liposome tracking with PET
|
Gawne, P.
|
|
2019
|
118-119 |
S1 |
p. S35-S36
|
artikel
|
| 110 |
New neutral and cationic “2+1” Re/99mTc(CO)3 complexes with 1,3,5-triaza-7-phosphaadamantane and its N-benzyl derivative
|
Ischyropoulou, M.
|
|
2019
|
118-119 |
S1 |
p. S27-S28
|
artikel
|
| 111 |
New tricarbonylrhenium(I) complexes: from structural study to a potential therapeutic radiopharmaceutical to target hepatocellular carcinoma metastases
|
Eychenne, R.
|
|
2019
|
118-119 |
S1 |
p. S4
|
artikel
|
| 112 |
Novel 4-nitroimidazole isocyanide labelled with 99mTc(I) core and [99mTc(I)(CO)3]+ core as potential tumor hypoxia imaging agents
|
Ruan, Q.
|
|
2019
|
118-119 |
S1 |
p. S62
|
artikel
|
| 113 |
Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy
|
Mairs, Rob J.
|
|
2008
|
118-119 |
S1 |
p. S9-S20
12 p.
|
artikel
|
| 114 |
Organometallic 99mTc/186Re-NOTA and NODAGA complexes utilizing a GRPR-targeting peptide antagonist
|
Makris, G.
|
|
2019
|
118-119 |
S1 |
p. S3-S4
|
artikel
|
| 115 |
Overcoming challenges for immunoreactivity assessment of radiolabeled antibodies
|
Beckford, V.
|
|
2019
|
118-119 |
S1 |
p. S52
|
artikel
|
| 116 |
Overcoming immune-barrier: cell membrane cloaked zirconium-89 hollow mesoporous silica nanospheres
|
Jun Young, Y.
|
|
2019
|
118-119 |
S1 |
p. S43
|
artikel
|
| 117 |
PET-MR amenable theranostic perfluorocarbon nanoemulsion for targeting inflammation
|
Nyiranshuti, L.
|
|
2019
|
118-119 |
S1 |
p. S38
|
artikel
|
| 118 |
Photonuclear production of high specific activity copper-67 and scandium-47
|
Rotsch, D.
|
|
2019
|
118-119 |
S1 |
p. S7
|
artikel
|
| 119 |
Photoreduction of Tc-99 pertechnetate to Tc (IV) by polyoxometalates and titanium dioxide and speciation of stabilized Tc(IV)
|
Burton-Pye, B.
|
|
2019
|
118-119 |
S1 |
p. S5
|
artikel
|
| 120 |
PLGA nanoparticles for combined SPECT/PET and 19F MRI in vivo cell tracking
|
Krekorian, M.
|
|
2019
|
118-119 |
S1 |
p. S42-S43
|
artikel
|
| 121 |
Polymersomes in alpha radionuclide therapy
|
De Kruijff, R.
|
|
2019
|
118-119 |
S1 |
p. S9
|
artikel
|
| 122 |
Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors
|
Norenberg, J.
|
|
2019
|
118-119 |
S1 |
p. S60
|
artikel
|
| 123 |
Preclinical evaluation of a [89Zr]-labeled elastin-specific tracer for imaging of pulmonary fibrosis
|
Burkemper, J.
|
|
2019
|
118-119 |
S1 |
p. S19
|
artikel
|
| 124 |
Preclinical evaluation of 64Cu-labeled monomeric and trimeric (RGDfK) conjugates based on a novel chelating platform
|
Bartholomä, M.
|
|
2019
|
118-119 |
S1 |
p. S18
|
artikel
|
| 125 |
Preliminary study on 64Cu-labeled tetraiodothyroacetic acid derivative for tumor angiogenesis imaging
|
Choe, Y.
|
|
2019
|
118-119 |
S1 |
p. S56
|
artikel
|
| 126 |
Pretargeted 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma: evaluating DNA-damage with 89Zr-PET
|
Poty, S.
|
|
2019
|
118-119 |
S1 |
p. S15-S16
|
artikel
|
| 127 |
Production of 225Ac and 225Ra for targeted alpha therapy via spallation on thorium: overview of radiochemical strategies and need for separation from large thorium targets
|
Radchenko, V.
|
|
2019
|
118-119 |
S1 |
p. S5
|
artikel
|
| 128 |
Production of a 52Mn-labeled PSMA-selective bimodal PET/MR probe
|
Giesen, K.
|
|
2019
|
118-119 |
S1 |
p. S13
|
artikel
|
| 129 |
Production of emerging positron emitting radiometal zirconium-89 with RFT-30 cyclotron
|
Vyas, C.
|
|
2019
|
118-119 |
S1 |
p. S32-S33
|
artikel
|
| 130 |
Production of 47Sc on 48Ca targets
|
Walczak, R.
|
|
2019
|
118-119 |
S1 |
p. S48
|
artikel
|
| 131 |
Production, purification and use of 66Ga for “in vivo” screening of therapeutic compounds
|
Amor-Coarasa, A.
|
|
2019
|
118-119 |
S1 |
p. S31
|
artikel
|
| 132 |
Prospects for Sc-47 production in nuclear reactor
|
Zoltowska, M.
|
|
2019
|
118-119 |
S1 |
p. S7
|
artikel
|
| 133 |
Quantification of inhaled aerosol particles composed of toxic disinfectant by using radioanalytical method
|
Jeon, J.
|
|
2019
|
118-119 |
S1 |
p. S43
|
artikel
|
| 134 |
Quantitative assessment of fluorescence uptake by dual labeling
|
Azhdarinia, A.
|
|
2019
|
118-119 |
S1 |
p. S54
|
artikel
|
| 135 |
Radioiodinated MIBG in paraganglioma and pheochromocytoma: previous results and early experiences using no-carrier-added MIBG
|
James, Olga
|
|
2008
|
118-119 |
S1 |
p. S63-S76
14 p.
|
artikel
|
| 136 |
Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma
|
DuBois, Steven G.
|
|
2008
|
118-119 |
S1 |
p. S35-S48
14 p.
|
artikel
|
| 137 |
Radiolabeling and proof-of-principle in vivo studies using actinium-225 produced at TRIUMF’s isotope separation on-line facility
|
Ramogida, C.
|
|
2019
|
118-119 |
S1 |
p. S9-S10
|
artikel
|
| 138 |
Radiometal-labeled bombesin derivatives for preclinical imaging
|
Ferguson, S.
|
|
2019
|
118-119 |
S1 |
p. S35
|
artikel
|
| 139 |
Radiopharmacological evaluation of novel 68Ga labeled peptide conjugates for potential use in imaging of gliomas
|
Lu, G.
|
|
2019
|
118-119 |
S1 |
p. S48
|
artikel
|
| 140 |
188Re-SSS/Lipiodol for HCC treatment: from (radio)chemistry to preliminary clinical results
|
Lepareur, N.
|
|
2019
|
118-119 |
S1 |
p. S46
|
artikel
|
| 141 |
Rhenium(I) DNA-intercalating complexes as anticancer agents
|
Kaplanis, M.
|
|
2019
|
118-119 |
S1 |
p. S24
|
artikel
|
| 142 |
44Sc-labeling of RM2 as potential imaging and dosimetry agent of prostate cancer
|
Eppard, E.
|
|
2019
|
118-119 |
S1 |
p. S45
|
artikel
|
| 143 |
47Sc targetry: investigating the production of 47Sc from 48Ti toward use in targeted radiotherapy
|
Phipps, M.
|
|
2019
|
118-119 |
S1 |
p. S33
|
artikel
|
| 144 |
Selective detection of alphavbeta3 integrin receptors using [99mTc(N)PNP]-labelled RGDechi peptides
|
Bolzati, C.
|
|
2019
|
118-119 |
S1 |
p. S56-S57
|
artikel
|
| 145 |
Speciation of technetium-99 in ionic liquids
|
Hatcher, J.
|
|
2019
|
118-119 |
S1 |
p. S26-S27
|
artikel
|
| 146 |
SPECT/CT imaging of cancer stem cells in aggressive prostate cancer using a 67Ga labeled anti-CD44v6 antibody
|
Prater, A.
|
|
2019
|
118-119 |
S1 |
p. S17
|
artikel
|
| 147 |
Supramolecular interaction of caffeine molecules with each other, water molecules and oxygen atoms in the cobalt, cadmium and magnesium perrhenates of caffeine
|
German, K.
|
|
2019
|
118-119 |
S1 |
p. S26
|
artikel
|
| 148 |
Synthesis and biodistribution of 99mTc(CO)3-CPA-2NM as a novel tumor hypoxia imaging agent
|
Lin, X.
|
|
2019
|
118-119 |
S1 |
p. S23-S24
|
artikel
|
| 149 |
Synthesis and biological evaluation of 99mTc-ATRIDAT-methoxyphenylpiperazine radioligand for 5-HT1A receptor imaging
|
Mishra, A.
|
|
2019
|
118-119 |
S1 |
p. S59
|
artikel
|
| 150 |
Synthesis and characterization of Re(CO)3 + and 99mTc(CO)3 + dithiocarbamate-isocyanide “2 + 1” mixed ligand complexes using [Cu(MIBI)4]BF4
|
Makrypidi, K.
|
|
2019
|
118-119 |
S1 |
p. S66
|
artikel
|
| 151 |
Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands
|
Salvarese, N.
|
|
2019
|
118-119 |
S1 |
p. S5-S6
|
artikel
|
| 152 |
Synthesis and evaluation of a fac-[Re(CO)3]+ complex bearing 2-(4’-aminophenyl)benzothiazole as anticancer agent
|
Mavroidi, B.
|
|
2019
|
118-119 |
S1 |
p. S50
|
artikel
|
| 153 |
Synthesis and evaluation of a 99mTc(CO)3-labelled palbociclib derivative to target cyclin-dependent kinase 4/6 for tumor imaging
|
Song, X.
|
|
2019
|
118-119 |
S1 |
p. S61
|
artikel
|
| 154 |
Synthesis and evaluation of a 99mTc-labeled hexavalent targeting probe from a monovalent ligand for in vivo imaging of saturable systems
|
Mizuno, Y.
|
|
2019
|
118-119 |
S1 |
p. S3
|
artikel
|
| 155 |
Synthesis and evaluation of 99mTc-HYNIC-RM2: a novel SPECT based gastrin releasing peptide receptor antagonist
|
Vats, K.
|
|
2019
|
118-119 |
S1 |
p. S29
|
artikel
|
| 156 |
Synthesis and evaluation of [2+1] Re(I)/Tc(I) complexes as isostructural optical and nuclear probes for imaging prostate cancer
|
Yazdani, A.
|
|
2019
|
118-119 |
S1 |
p. S27
|
artikel
|
| 157 |
Synthesis and labelling of a phenylboranate derivative with 68Ga for molecular recognition of overexpressed sialic acid on tumor cells
|
Shegani, A.
|
|
2019
|
118-119 |
S1 |
p. S40
|
artikel
|
| 158 |
Synthesis, characterization and in vitro biological assessment of novel mixed “2 + 1” rhenium (i) complexes with a benzothiazole derivative
|
Roupa, I.
|
|
2019
|
118-119 |
S1 |
p. S1
|
artikel
|
| 159 |
Synthesis, characterization and labeling of [64Cu]-5-(4-aminophenyl)-10,15,20-triphenyl porphyrine as a potential PET imaging chelate
|
Aguilar-Ortiz, E.
|
|
2019
|
118-119 |
S1 |
p. S36
|
artikel
|
| 160 |
Synthesis of bifunctional HBED-based complexing ligands for use in theragnostic radiopharmaceuticals
|
Makarem, A.
|
|
2019
|
118-119 |
S1 |
p. S40-S41
|
artikel
|
| 161 |
Synthesis of rhenium and technetium N2O2 Schiff base complexes
|
Baumeister, J.
|
|
2019
|
118-119 |
S1 |
p. S27
|
artikel
|
| 162 |
Synthesis of [99TcX(CO)5] (X = Cl, Br, I) at ambient pressure
|
Miroslavov, A.
|
|
2019
|
118-119 |
S1 |
p. S24
|
artikel
|
| 163 |
Synthesis of triphenylphosphonium cation and folic acid conjugated 89Zr-labeled silica nanoparticles for cancer imaging agent
|
Park, J.
|
|
2019
|
118-119 |
S1 |
p. S51
|
artikel
|
| 164 |
Synthesis, stability, and in vivo imaging of the indirect incorporation of arsenic-72 on therapeutic antibodies
|
Kim, J.
|
|
2019
|
118-119 |
S1 |
p. S45-S46
|
artikel
|
| 165 |
Targeted radiopharmaceuticals for nuclear imaging and radiotherapy of CD133-positive tumors
|
Wyszatko, K.
|
|
2019
|
118-119 |
S1 |
p. S49
|
artikel
|
| 166 |
Targeting CD38 for theranostics of lymphoma with 89Zr and 177Lu
|
Cai, W.
|
|
2019
|
118-119 |
S1 |
p. S17
|
artikel
|
| 167 |
Targeting the GLP-1 receptor on pancreatic beta-cells: signaling and radiopharmaceutical applications
|
Käppeli, S.
|
|
2019
|
118-119 |
S1 |
p. S54-S55
|
artikel
|
| 168 |
Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry
|
Henry, K.
|
|
2019
|
118-119 |
S1 |
p. S15
|
artikel
|
| 169 |
Technetium-99m labeled phenylquinoxaline derivatives as potential tau-selective imaging probes for diagnosis of Alzheimer’s disease
|
Yang, F.
|
|
2019
|
118-119 |
S1 |
p. S56
|
artikel
|
| 170 |
Technetium-99m radiolabeled glucagon-like peptide analog exendin-4 for cancer diagnosis
|
Ozgenc, E.
|
|
2019
|
118-119 |
S1 |
p. S49-S50
|
artikel
|
| 171 |
TECHN-OSP: Molybdenum target preparation techniques for cyclotron-based technetium-99m production
|
Skliarova, H.
|
|
2019
|
118-119 |
S1 |
p. S8
|
artikel
|
| 172 |
Tetrakis(3,4-hydroxypyridinone) bifunctional chelators for zirconium-89 imaging of antibodies
|
Morais, M.
|
|
2019
|
118-119 |
S1 |
p. S34
|
artikel
|
| 173 |
The application of polyoxometalates to thorium debulking studies for actinium-225 production
|
Hatcher, J.
|
|
2019
|
118-119 |
S1 |
p. S20-S21
|
artikel
|
| 174 |
The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors: a meta-analysis
|
Dannoon, S.
|
|
2019
|
118-119 |
S1 |
p. S48
|
artikel
|
| 175 |
The optimization of click-mediated pretargeted radioimmunotherapy
|
Membreno, R.
|
|
2019
|
118-119 |
S1 |
p. S17-S18
|
artikel
|
| 176 |
The possibility of producing 43Sc from 44Ca via the (p,2n) nuclear reaction
|
Van der Meulen, N.
|
|
2019
|
118-119 |
S1 |
p. S9
|
artikel
|
| 177 |
Theranostic 203/212Pb-labeled octreotate analogs (AlphaMedix TM) and their preclinical characterization for the Phase I clinical studies in neuroendocrine cancer patients
|
Tworowska, I.
|
|
2019
|
118-119 |
S1 |
p. S19-S20
|
artikel
|
| 178 |
Theranostics of angiogenic tumors with 86/90Y-labeled antibodies
|
Ehlerding, E.
|
|
2019
|
118-119 |
S1 |
p. S59
|
artikel
|
| 179 |
Title Page
|
|
|
2019
|
118-119 |
S1 |
p. iii
|
artikel
|
| 180 |
Trastuzumab co-treatment improves survival of mice with PC-3 prostate cancer xenografts treated with [177Lu]Lu-DOTAGA-PEG2-RM26 GRPR antagonists
|
Mitran, B.
|
|
2019
|
118-119 |
S1 |
p. S21-S22
|
artikel
|
| 181 |
1,4,7-Triazacyclononane: an effective chelator for copper-64
|
Kubeil, M.
|
|
2019
|
118-119 |
S1 |
p. S13-S14
|
artikel
|
| 182 |
Ultrasmall silicon nanoparticles as promising platform for targeted multimodal imaging
|
Zarschler, K.
|
|
2019
|
118-119 |
S1 |
p. S59-S60
|
artikel
|
| 183 |
US DOE tri-lab effort to produce actinium-225
|
Cutler, C.
|
|
2019
|
118-119 |
S1 |
p. S8
|
artikel
|
| 184 |
Use of magnetron sputtering technique for medical cyclotron solid target preparation
|
Skliarova, H.
|
|
2019
|
118-119 |
S1 |
p. S31
|
artikel
|
| 185 |
What was it like to hit upon the “Theragnostics” Paradigm: “A Personal Journey” at Brookhaven National Laboratory
|
Srivastava, S.
|
|
2019
|
118-119 |
S1 |
p. S47
|
artikel
|
| 186 |
89Zr-atezolizumab conjugation strategies
|
Carney, B.
|
|
2019
|
118-119 |
S1 |
p. S65-S66
|
artikel
|
| 187 |
89Zr-incorporated iron oxide nanocluster by chelator-free simple direct-labelling method for PET diagnosis
|
Choi, P.
|
|
2019
|
118-119 |
S1 |
p. S63
|
artikel
|
| 188 |
[89Zr]Zirconium: dissolution and purification process based on commercial, cassette base, synthesis module
|
Cazzola, E.
|
|
2019
|
118-119 |
S1 |
p. S33
|
artikel
|
Tijdschrift beschrijving